StocksRunner logo
 
 
 
 
»
 

Snowflake Surpasses Analysts Expectations in Q4, But Disappoints with Lower Revenue Forecast for Next Year

 
 
 
 

stocks on the run

 
 
 

Snowflake, a company that offers cloud-based data storage services, has announced its Q4 revenue of $589 million, surpassing the expected figure of $575.9 million. Additionally, the profit per share has been reported to be $0.14, exceeding the estimated $0.04. However, the stock prices have declined after the company's projection of a revenue forecast between $568-573 million, falling short of the predicted amount of $582.1 million.

 

The company's anticipated product revenues for the whole year are $2.7 billion, which is lower than the forecasted amount of $2.99 billion by analysts. Moreover, the board of directors has authorized a share repurchase program of up to $2 billion, which will expire in March 2025.

 

A William Blair analyst pointed out that Snowflake has expanded its agreement with Amazon's cloud computing service and has been working on creating new products, which are expected to bolster the company's financial standing. According to the analyst.

 

"We are optimistic about Snowflake's potential to achieve its long-term objectives and forecast that the company may achieve a free cash flow margin of 30% within the next few years."

 

According to its latest financial statements, the company's product revenue has surged by 17%, with anticipated full-year revenue of $1.9 billion. This exceeds the analysts' expectations of $1.89 billion. The company has also achieved a profit margin of 75% for product revenue, surpassing the predicted 74.6%. Additionally, the general operating profit margin has been reported to be 2%, while the free cash flow margin is expected to be 17%, which is higher than the expected margin of 16.1% by analysts.

 

Established in 2012 and went public in 2020, Snowflake currently has a workforce of around 3,992 employees. The company has a customer base of 7,828, and out of these, 330 customers generate annual revenue of over one million dollars each. Unfortunately, the company's stock has dropped by approximately 38% from its initial public offering (IPO) price and is currently trading at a market valuation of about 42.9 billion dollars, with a high forward earnings multiple of 302.6.

 
 

stocks on the run

 
 
 
unlock
 
 
 

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner

StocksRunner

Get the pulse of the market

 
 
 
StocksRunner

Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.